Furthermore, the API market is becoming increasingly globalized. Many pharmaceutical companies source their APIs from manufacturers worldwide to reduce costs and improve production efficiencies. However, this globalization brings challenges, such as ensuring compliance with various international regulations, maintaining quality control, and managing procurement risks.
In recent years, the field of anti-aging research has garnered significant attention, and one compound that stands out is β-Nicotinamide Mononucleotide (NMN). NMN is a nucleotide derived from ribose and nicotinamide, a form of vitamin B3. It plays a vital role in the synthesis of nicotinamide adenine dinucleotide (NAD+), a coenzyme that is crucial for various biological processes, including energy metabolism, DNA repair, and cell signaling. Given its critical functions, NMN has become a focal point in the quest for longevity and improved health in aging populations.